Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration … AJM Van den Eertwegh, J Versluis, HP Van den Berg, SJAM Santegoets, ... The lancet oncology 13 (5), 509-517, 2012 | 396 | 2012 |
NKG2A blockade potentiates CD8 T cell immunity induced by cancer vaccines N van Montfoort, L Borst, MJ Korrer, M Sluijter, KA Marijt, SJ Santegoets, ... Cell 175 (7), 1744-1755. e15, 2018 | 289 | 2018 |
Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses MJ Welters, TC van der Sluis, H van Meir, NM Loof, VJ van Ham, ... Science translational medicine 8 (334), 334ra52-334ra52, 2016 | 204 | 2016 |
Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry SJAM Santegoets, EM Dijkgraaf, A Battaglia, P Beckhove, CM Britten, ... Cancer Immunology, Immunotherapy 64, 1271-1286, 2015 | 200 | 2015 |
Intratumoral HPV16-specific T cells constitute a type I–oriented tumor microenvironment to improve survival in HPV16-driven oropharyngeal cancer MJP Welters, W Ma, SJAM Santegoets, R Goedemans, I Ehsan, ... Clinical Cancer Research 24 (3), 634-647, 2018 | 167 | 2018 |
A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer EM Dijkgraaf, S Santegoets, AKL Reyners, R Goedemans, MCA Wouters, ... Annals of Oncology 26 (10), 2141-2149, 2015 | 161 | 2015 |
CXCL12 is essential for migration of activated Langerhans cells from epidermis to dermis K Ouwehand, SJAM Santegoets, DP Bruynzeel, RJ Scheper, TD de Gruijl, ... European journal of immunology 38 (11), 3050-3059, 2008 | 157 | 2008 |
Local administration of PF-3512676 CpG-B instigates tumor-specific CD8+ T-cell reactivity in melanoma patients BG Molenkamp, BJR Sluijter, PAM van Leeuwen, SJAM Santegoets, ... Clinical Cancer Research 14 (14), 4532-4542, 2008 | 153 | 2008 |
Transcriptional profiling of human dendritic cell populations and models-unique profiles of in vitro dendritic cells and implications on functionality and applicability K Lundberg, AS Albrekt, I Nelissen, S Santegoets, TD de Gruijl, S Gibbs, ... PloS one 8 (1), e52875, 2013 | 129 | 2013 |
Human dendritic cell line models for DC differentiation and clinical DC vaccination studies SJAM Santegoets, AJM van den Eertwegh, AA van de Loosdrecht, ... Journal of Leucocyte Biology 84 (6), 1364-1373, 2008 | 120 | 2008 |
Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab SJAM Santegoets, AGM Stam, SM Lougheed, H Gall, K Jooss, N Sacks, ... Journal for immunotherapy of cancer 2, 1-12, 2014 | 108 | 2014 |
A CD34+ human cell line model of myeloid dendritic cell differentiation: evidence for a CD14+CD11b+ Langerhans cell precursor SJAM Santegoets, AJ Masterson, PC Van Der Sluis, SM Lougheed, ... Journal of leukocyte biology 80 (6), 1337-1344, 2006 | 102 | 2006 |
T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment SJAM Santegoets, AGM Stam, SM Lougheed, H Gall, PET Scholten, ... Cancer Immunology, Immunotherapy 62, 245-256, 2013 | 101 | 2013 |
IL-21 promotes the expansion of CD27+CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells SJAM Santegoets, AW Turksma, MM Suhoski, AGM Stam, SM Albelda, ... Journal of translational medicine 11, 1-10, 2013 | 98 | 2013 |
CD39 Identifies the CD4+ Tumor-Specific T-cell Population in Human Cancer KE Kortekaas, SJ Santegoets, G Sturm, I Ehsan, SL van Egmond, ... Cancer immunology research 8 (10), 1311-1321, 2020 | 94 | 2020 |
Research resource: transcriptome profiling of genes regulated by RXR and its permissive and nonpermissive partners in differentiating monocyte-derived dendritic cells L Szeles, S Poliska, G Nagy, I Szatmari, A Szanto, A Pap, M Lindstedt, ... Molecular endocrinology 24 (11), 2218-2231, 2010 | 93 | 2010 |
In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line SJAM Santegoets, MWJ Schreurs, AJ Masterson, YP Liu, S Goletz, ... Cancer Immunology, Immunotherapy 55, 1480-1490, 2006 | 86 | 2006 |
Impact of varicella-zoster virus on dendritic cell subsets in human skin during natural infection JH Huch, AL Cunningham, AM Arvin, N Nasr, SJAM Santegoets, ... Journal of virology 84 (8), 4060-4072, 2010 | 84 | 2010 |
Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer AH Kverneland, M Pedersen, MCW Westergaard, M Nielsen, TH Borch, ... Oncotarget 11 (22), 2092, 2020 | 82 | 2020 |
A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia AA van de Loosdrecht, S van Wetering, SJAM Santegoets, SK Singh, ... Cancer Immunology, Immunotherapy 67, 1505-1518, 2018 | 79 | 2018 |